Literature DB >> 18548193

Metastatic oligodendrogliomas: a review of the literature and case report.

F Zustovich1, A Della Puppa, R Scienza, P Anselmi, C Furlan, G Cartei.   

Abstract

Oligodendroglioma cells are detectable in the cerebro-spinal fluid in up to 14% of patients [10] and cerebellar and/or spinal cord involvement is a well known phenomenon [3]. Distant spread of oligodendroglioma is exceptional, probably due to the presence of the blood-brain barrier, the absence of lymphatic vessels and the short survival of patients. A review of the worldwide literature yielded 32 previously reported examples since 1951 to the present (Tab1e 1). This review was performed using NCBI-PubMed and "oligodendroglioma, oligodendrogliomas, metastatic, metastasis, metastases, extraneural", in different combinations, as key words and reviewing the bibliography of the consequent selected articles. New therapeutic approaches are prolonging the overall survival of patients with primitive brain tumours and in particular of those with high grade oligodendroglioma which is a chemo-sensitive disease. A longer overall survival could increase the risk of extracranial dissemination of gliomas that in the future might become a less rare clinical complication.

Entities:  

Mesh:

Year:  2008        PMID: 18548193     DOI: 10.1007/s00701-008-1507-z

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  14 in total

Review 1.  Cervical lymph node metastases from remote primary tumor sites.

Authors:  Fernando López; Juan P Rodrigo; Carl E Silver; Missak Haigentz; Justin A Bishop; Primož Strojan; Dana M Hartl; Patrick J Bradley; William M Mendenhall; Carlos Suárez; Robert P Takes; Marc Hamoir; K Thomas Robbins; Ashok R Shaha; Jochen A Werner; Alessandra Rinaldo; Alfio Ferlito
Journal:  Head Neck       Date:  2015-12-29       Impact factor: 3.147

2.  Interventricular low-grade oligodendroglioma with multiple parenchymal relapse.

Authors:  Ali Akhavan; Fariba Binesh; Afshin Rakhsha; Hossein Navabii
Journal:  BMJ Case Rep       Date:  2012-06-08

3.  Unusual intracranial spread of anaplastic oligodendroglioma.

Authors:  Ali Akhavan; Fariba Binesh; Hossein Navabii
Journal:  BMJ Case Rep       Date:  2012-08-13

Review 4.  A survey of metastatic central nervous system tumors to cervical lymph nodes.

Authors:  Vanni Mondin; Alfio Ferlito; Kenneth O Devaney; Julia A Woolgar; Alessandra Rinaldo
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-08-08       Impact factor: 2.503

5.  Oligodendroglioma metastasis to the bone marrow mimicking multiple myeloma: A case report.

Authors:  Yuan Jian; Wen Gao; Yin Wu; Yanchen Li; Yong Zhang; Guangzhong Yang; Wenming Chen
Journal:  Oncol Lett       Date:  2016-05-13       Impact factor: 2.967

6.  Intramedullary spinal cord and leptomeningeal metastases from intracranial low-grade oligodendroglioma.

Authors:  Nipun Verma; Craig Nolan; Miki Hirano; Robert J Young
Journal:  Clin Imaging       Date:  2014-03-06       Impact factor: 1.605

7.  Genetic markers in oligodendroglial tumours.

Authors:  Tomaz Velnar; Uros Smrdel; Mara Popovic; Gorazd Bunc
Journal:  Radiol Oncol       Date:  2010-03-18       Impact factor: 2.991

Review 8.  Occipital anaplastic oligodendroglioma with multiple organ metastases after a short clinical course: a case report and literature review.

Authors:  Gang Li; Zhiguo Zhang; Jianghong Zhang; Tianbo Jin; Hongjuan Liang; Li Gong; Guangbin Cui; Haixia Yang; Shiming He; Yongsheng Zhang; Guodong Gao
Journal:  Diagn Pathol       Date:  2014-01-21       Impact factor: 2.644

Review 9.  Postoperative extracranial metastasis from glioblastoma: a case report and review of the literature.

Authors:  Wenjiao Wu; Dequan Zhong; Zhan Zhao; Wentao Wang; Jun Li; Wei Zhang
Journal:  World J Surg Oncol       Date:  2017-12-29       Impact factor: 2.754

10.  Extra-neural metastases of malignant gliomas: myth or reality?

Authors:  Patrick Beauchesne
Journal:  Cancers (Basel)       Date:  2011-01-27       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.